Sofinnova Capital VII FCPR, 10% Owner at Shockwave Medical, Inc. (SWAV), sold 235,266 shares at $45.04 ($10.6M) on 2020-06-05, disclosed to the SEC on 2020-06-08.
Scheduled sale ($10.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.03 | 4,000 | $180K | 1.7% |
| 2 | $45.04 | 55,754 | $2.5M | 23.7% |
| 3 | $45.04 | 55,754 | $2.5M | 23.7% |
| 4 | $45.11 | 59,879 | $2.7M | 25.5% |
| 5 | $45.11 | 59,879 | $2.7M | 25.5% |
| Total | $45.08 avg | 235,266 |
| $10.6M |
| 100% |
| Filing → |
| SWAV | SELL | 2020-08-14 | $1.5M | — | Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |